![Paddy McDermott](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paddy McDermott
Presidente presso Transitions Optical, Inc.
Posizioni attive di Paddy McDermott
Società | Posizione | Inizio | Fine |
---|---|---|---|
Transitions Optical, Inc.
![]() Transitions Optical, Inc. Electronic ComponentsElectronic Technology Transitions Optical, Inc. manufactures photochromic ophthalmic lenses. It offers its products through eye care professionals and retail locations. The firm offers eyeglass lenses and sunglasses and shields. The company was founded in 1990 and is headquartered in Pinellas Park, FL. | Direttore/Membro del Consiglio | - | - |
Presidente | - | - | |
National Society to Prevent Blindness
![]() National Society to Prevent Blindness Miscellaneous Commercial ServicesCommercial Services National Society to Prevent Blindness operates as an eye health and safety organization. It offers services for amblyopia, AMD, cataract, central retinal vein occlusion, colour blindness, conjunctivitis, diabetic eye disease and macular enema, dry eye, floaters, glaucoma, refractive eye, retinal tears and detachments, retinitis pigments and strabismus. The company was founded in 1908 and is headquartered in Chicago, IL. | Direttore/Membro del Consiglio | - | - |
Mirai Medical Ltd.
![]() Mirai Medical Ltd. Information Technology ServicesTechnology Services Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Paddy McDermott
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Irlanda | 2 |
Posizioni
Director/Board Member | 3 |
President | 1 |
Settori
Commercial Services | 2 |
Electronic Technology | 2 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
National Society to Prevent Blindness
![]() National Society to Prevent Blindness Miscellaneous Commercial ServicesCommercial Services National Society to Prevent Blindness operates as an eye health and safety organization. It offers services for amblyopia, AMD, cataract, central retinal vein occlusion, colour blindness, conjunctivitis, diabetic eye disease and macular enema, dry eye, floaters, glaucoma, refractive eye, retinal tears and detachments, retinitis pigments and strabismus. The company was founded in 1908 and is headquartered in Chicago, IL. | Commercial Services |
Transitions Optical, Inc.
![]() Transitions Optical, Inc. Electronic ComponentsElectronic Technology Transitions Optical, Inc. manufactures photochromic ophthalmic lenses. It offers its products through eye care professionals and retail locations. The firm offers eyeglass lenses and sunglasses and shields. The company was founded in 1990 and is headquartered in Pinellas Park, FL. | Electronic Technology |
Mirai Medical Ltd.
![]() Mirai Medical Ltd. Information Technology ServicesTechnology Services Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then. | Technology Services |
- Borsa valori
- Insiders
- Paddy McDermott
- Esperienza